Bcl-2-IN-10

Modify Date: 2024-04-06 12:33:48

Bcl-2-IN-10 Structure
Bcl-2-IN-10 structure
Common Name Bcl-2-IN-10
CAS Number 2773354-28-0 Molecular Weight 635.50
Density N/A Boiling Point N/A
Molecular Formula C22H25N11O12 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Bcl-2-IN-10


Bcl-2-IN-10 is an active Bcl-2 inhibitor that can release up to four nitric oxide (NO) molecules. Bcl-2-IN-10 has cytotoxic activities against cancer cells, such as human leukemia, breast cancer and lung cancer. Bcl-2-IN-10 induces cell apopotosis and arrest cell cycle of G2/M phase, and can be used in cancer-related research[1].

 Names

Name Bcl-2-IN-10

 Bcl-2-IN-10 Biological Activity

Description Bcl-2-IN-10 is an active Bcl-2 inhibitor that can release up to four nitric oxide (NO) molecules. Bcl-2-IN-10 has cytotoxic activities against cancer cells, such as human leukemia, breast cancer and lung cancer. Bcl-2-IN-10 induces cell apopotosis and arrest cell cycle of G2/M phase, and can be used in cancer-related research[1].
Related Catalog
Target

Bax

In Vitro Steroid sulfatase-IN-2 (compound 1, 0-20 μM approximately, 72 h) inhibits different cancer cells with IC50s ranging from 1.26 μM to 17.86 μM[1]. Steroid sulfatase-IN-2 (1 μM, 5 h) releases up to four molecules of nitric oxide[1]. Steroid sulfatase-IN-2 (8 μM, 8-72 h) induces leukemia cell CCRF-CEM apoptosis via MAPKs pathways, arrests cell in the G2/M phase, and increases ratio of Bax/Bcl-2[1]. Apoptosis Analysis[1] Cell Line: CEM cells Concentration: 8 μM Incubation Time: 8, 24, 48 or 72 h Result: Induced apoptosis in a time-dependent and dose-dependent manner. Cell Cycle Analysis[1] Cell Line: CEM cells Concentration: 8 μM Incubation Time: 8, 24, 48 or 72 h Result: Arrested cell in the G2/M phase. Western Blot Analysis[1] Cell Line: CEM cells Concentration: 0-8 μM Incubation Time: 72 h Result: Increased the levels of JNK and p38, and the levels of phosphorylated JNK and p38. Decreased Bcl-2 level in a time- and dose-dependent manner, and increased pro-apoptotic Bax level.
References

[1]. Xun Ji, et al. Double-component diazeniumdiolate derivatives as anti-cancer agents. Bioorg Med Chem. 2020 Apr 15;28(8):115405.

 Chemical & Physical Properties

Molecular Formula C22H25N11O12
Molecular Weight 635.50